4
Changes in Ownership
ORAMED PHARMACEUTICALS INC. Filed Acc 0001213900-18-005618
Options or other derivatives
- Chief Operating Officer acquired 30,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Hexter Joshua Chief Operating Officer | 2018-05-03 | Grant or award · Stock option (right to buy) | +30,000 | 30,000 | D | ||
Loading xslF345X03/f4050318hexter_oramedpharm.xml…